Healthcare Sector

XOMA

Market Tracker

$25.51
-0.15
(-0.58%)
4:52 pm
Next Earnings: (est.) 08/05/23 12:00 am
  • XOMA (Selected)

    XOMA Corporation
  • XOMAO

    XOMA Corporation
  • XOMAP

    XOMA Corporation

XOMA Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

XOMA Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

XOMA Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

XOMA Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

XOMA Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
12/20/2024 PUT $15.00 2 +2
12/20/2024 PUT $17.50 2 +2
07/19/2024 PUT $20.00 1 +1
09/20/2024 PUT $17.50 2 +1 +100.00%
12/20/2024 PUT $12.50 1 +1
05/17/2024 CALL $15.00 0 0
12/20/2024 CALL $35.00 0 0
12/20/2024 PUT $20.00 0 0
12/20/2024 PUT $22.50 3 0
12/20/2024 PUT $25.00 0 0
12/20/2024 PUT $30.00 0 0
12/20/2024 PUT $35.00 0 0

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

XOMA Major Holders

Name Pct Held Shares Total
Variable Insurance Products Fund-Growth Portfolio 3.35% 384.5k 6.41M
Fidelity Capital Appreciation Fund 2.58% 296k 4.93M
Fidelity Advisor Equity Growth Fund 2.54% 291.1k 4.85M
Vanguard Total Stock Market Index Fund 1.94% 222k 3.7M
Fidelity Growth Discovery Fund 1.41% 162.1k 2.7M
Vanguard Extended Market Index Fund 0.60% 68.35k 1.14M
Fidelity Advisor Series Equity Growth Fund 0.49% 55.68k 928.13k
Fidelity Select Portfolios - Pharmaceuticals 0.47% 53.3k 888.51k
Fidelity Extended Market Index Fund 0.35% 40.57k 676.37k
Avantis U.S. Small Cap Value ETF 0.23% 26.05k 434.25k

XOMA News

  • XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ

    05/14 07:30 am

    GlobeNewswire Inc.

    Read more
  • Certara, Inc. (CERT) Q1 Earnings Meet Estimates

    05/07 06:40 pm

    Zacks Investment Research

    Read more
  • Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Misses Revenue Estimates

    05/02 06:05 pm

    Zacks Investment Research

    Read more
  • XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%

    04/30 07:30 am

    GlobeNewswire Inc.

    Read more
  • Cracking The Code: Understanding Analyst Reviews For XOMA

    04/29 10:00 am

    Benzinga

    Read more
  • XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)

    04/25 07:30 am

    GlobeNewswire Inc.

    Read more
  • XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.

    03/19 04:05 pm

    GlobeNewswire Inc.

    Read more
  • XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value

    03/08 08:30 am

    GlobeNewswire Inc.

    Read more
  • XOMA to Present at Upcoming Investor Conferences in March

    02/28 08:30 am

    GlobeNewswire Inc.

    Read more
  • XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right

    02/16 09:00 am

    GlobeNewswire Inc.

    Read more
  • XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition

    01/18 09:30 am

    GlobeNewswire Inc.

    Read more
  • FDA Acceptance of Zevra’s Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRx

    01/11 05:05 pm

    GlobeNewswire Inc.

    Read more
  • XOMA Announces Stock Repurchase Program of up to $50 Million

    01/02 08:30 am

    GlobeNewswire Inc.

    Read more
  • XOMA Declares Quarterly Preferred Stock Dividends

    12/20 08:30 am

    GlobeNewswire Inc.

    Read more
  • I'm Buying Preferred Stocks Hand Over Fist

    12/15 09:30 am

    Seeking Alpha

    Read more
  • XOMA Reports Third Quarter 2023 Financial Results and Highlights Upcoming Events Expected to Drive Shareholder Value

    11/07 08:30 am

    GlobeNewswire Inc.

    Read more
  • XOMA Earns $5 Million Milestone Upon FDA Acceptance of Day One’s Tovorafenib NDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)

    10/31 07:30 am

    GlobeNewswire Inc.

    Read more
  • Ride The Royalty Ripple To Riches Like Charlie Munger

    10/06 07:35 am

    Seeking Alpha

    Read more
  • XOMA Declares Quarterly Preferred Stock Dividends

    09/25 07:30 am

    GlobeNewswire Inc.

    Read more
  • Xoma (XOMA) Moves 7.7% Higher: Will This Strength Last?

    09/18 12:41 pm

    Zacks Investment Research

    Read more
  • XOMA to Present at H.C. Wainwright 25th Annual Global Investment Conference

    09/06 07:30 am

    GlobeNewswire Inc.

    Read more
  • XOMA Reports Second Quarter 2023 Financial Results and Provides Update on its Royalty Monetization Strategy

    08/08 07:30 am

    GlobeNewswire Inc.

    Read more
  • Castle Biosciences, Inc. (CSTL) Reports Q2 Loss, Tops Revenue Estimates

    08/02 06:15 pm

    Zacks Investment Research

    Read more
  • XOMA Added to the Russell 2000® and Russell 3000® Indexes

    06/23 06:14 pm

    GlobeNewswire Inc.

    Read more
  • Arimoclomol and Aldoxorubicin Acquisition to Bolster XOMA's Revenue Growth: Analyst

    06/22 03:09 pm

    Benzinga

    Read more
  • XOMA Acquires Royalty and Milestone Economics to Phase 3 First-In-Class Orphan Disease Asset for Niemann-Pick Disease Type C (NPC) and Phase 2 Oncology Asset

    06/22 07:30 am

    GlobeNewswire Inc.

    Read more
  • XOMA Declares Quarterly Preferred Stock Dividends

    06/20 07:30 am

    GlobeNewswire Inc.

    Read more
  • XOMA Reports First Quarter 2023 Financial Results and Provides Update on the Acceleration of its Differentiated Royalty Monetization Strategy

    05/09 07:30 am

    GlobeNewswire Inc.

    Read more
  • Strength Seen in Vertex (VRTX): Can Its 5.0% Jump Turn into More Strength?

    04/28 03:28 am

    Zacks Investment Research

    Read more
  • XOMA to Present at H.C. Wainwright BioConnect Investor Conference

    04/26 07:30 am

    GlobeNewswire Inc.

    Read more
  • XOMA Acquires Cashflow-Generating Asset for its Royalty and Milestone Portfolio

    03/30 07:30 am

    GlobeNewswire Inc.

    Read more
  • XOMA Declares Quarterly Preferred Stock Dividends

    03/21 07:30 am

    GlobeNewswire Inc.

    Read more
  • XOMA Reports Full-Year 2022 Financial Results and Provides Update to the Acceleration of its Differentiated Royalty Monetization Strategy

    03/09 08:30 am

    GlobeNewswire Inc.

    Read more
  • XOMA to Present at 43rd Annual Cowen Health Care Conference

    02/28 08:30 am

    GlobeNewswire Inc.

    Read more
  • XOMA Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    01/06 08:00 pm

    GlobeNewswire Inc.

    Read more
  • New Executive Leadership Team Appointed to Accelerate XOMA’s Differentiated Royalty Monetization Strategy

    01/04 08:30 am

    GlobeNewswire Inc.

    Read more
  • XOMA Declares Quarterly Preferred Stock Dividends

    12/22 08:30 am

    GlobeNewswire Inc.

    Read more
  • XOMA Acquires Royalty and Milestone License to Ebopiprant, a Preterm Labor Asset, Being Developed by Organon

    11/22 08:01 am

    GlobeNewswire Inc.

    Read more
  • XOMA Declares Quarterly Preferred Stock Dividends

    09/21 07:30 am

    GlobeNewswire Inc.

    Read more
  • Starbucks And 3 Other Stock Insiders Are Buying

    09/19 10:57 am

    Benzinga

    Read more
  • XOMA to Present at H.C. Wainwright 24th Annual Global Investment Conference

    09/07 07:30 am

    GlobeNewswire Inc.

    Read more
  • Xoma (XOMA) Reports Q2 Loss, Misses Revenue Estimates

    08/04 10:45 am

    Zacks Investment Research

    Read more
  • XOMA Reports Second Quarter 2022 Financial Results and Highlights Recent Operational Events

    08/04 07:30 am

    GlobeNewswire Inc.

    Read more
  • XOMA Declares Quarterly Preferred Stock Dividends

    06/20 07:30 am

    GlobeNewswire Inc.

    Read more
  • XOMA to Present at H.C. Wainwright Global Investment Conference

    05/17 04:05 pm

    GlobeNewswire Inc.

    Read more
  • Xoma (XOMA) Reports Q1 Loss, Misses Revenue Estimates

    05/05 08:55 am

    Zacks Investment Research

    Read more
  • Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Lags Revenue Estimates

    05/03 08:15 am

    Zacks Investment Research

    Read more
  • XOMA Declares Quarterly Preferred Stock Dividends

    03/21 07:30 am

    GlobeNewswire Inc.

    Read more
  • XOMA to Present at the 42nd Annual Cowen Health Care Conference

    03/01 08:30 am

    GlobeNewswire Inc.

    Read more
  • XOMA to Present at Aegis Capital Corp Investor Conference

    02/17 08:30 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: